We are live on
!
Find out more
PP
PrairieView Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
11.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
+11.4%
3 Year Est. Return
+34.04%
5 Year Est. Return
+51.99%
10 Year Est. Return
–
AUM
$625M
AUM Growth
+$57.6M
(+10%)
Cap. Flow
+$24.6M
Cap. Flow
% of AUM
3.93%
Top 10 Holdings %
Top 10 Hldgs %
62.67%
Holding
384
New
64
Increased
69
Reduced
65
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.4M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$4.77M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$4.37M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$3.65M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.82M |
| 2 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.14M |
| 3 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.12M |
| 4 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$718K |
| 5 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$384K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 3.06% |
| 2 | Financials | 1.17% |
| 3 | Technology | 1.16% |
| 4 | Communication Services | 0.61% |
| 5 | Healthcare | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Theriva Biologics
TOVX
$10.2M
| $0 | ﹤0.01% |
+2
| New | +$395 |
|
377
UWM Holdings
UWMC
$485M
| $0 | ﹤0.01% |
+8
| New | +$78 |
|
378
Viking Therapeutics
VKTX
$4B
| – | – |
-29
| Closed | – |
|
379
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
| $0 | ﹤0.01% |
+3
| New | +$239 |
|
380
Wabtec
WAB
$49.2B
| $0 | ﹤0.01% |
1
| – | – |
|
|
DM
381
DELISTED
Desktop Metal, Inc.
DM
| – | – |
0
| – | – |
|
|
ALR
382
DELISTED
AlerisLife Inc
ALR
| $0 | ﹤0.01% |
27
| – | – |
|
|
CVET
383
DELISTED
Covetrus, Inc. Common Stock
CVET
| – | – |
-126
| Closed | -$4K |
|
|
GNRS
384
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
| $0 | ﹤0.01% |
+10
| New | +$103 |
|
Similar funds
CCM
SAF
FC
NRD
GIM
SC
BWA
CCP
PrairieView Partners's Q1 2021 Portfolio in Review
As of Q1 2021, PrairieView Partners held 384 positions worth $625M, up 10% from $568M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
PrairieView Partners deployed $24.6M of net new capital in Q1 2021, opening 64 new positions and adding to 69 existing holdings. Its largest new stake was Mastercard: 1,055 shares worth $376K.
By sector, the portfolio is most concentrated in Industrials at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $3.82M trimmed.
- PrairieView Partners's largest Q1 2021 buy was Mastercard: 1,055 shares worth $376K.
- PrairieView Partners added most to Vanguard Short-Term Bond ETF in Q1 2021, an estimated $5.4M increase.
- PrairieView Partners's biggest Q1 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $3.82M.
- PrairieView Partners fully exited Moderna in Q1 2021, selling an estimated $87K.
- PrairieView Partners's ten largest holdings make up 63% of its $625M portfolio in Q1 2021.
- PrairieView Partners opened 64 new positions and closed 13 in Q1 2021.
- PrairieView Partners's portfolio value rose 10% quarter-over-quarter to $625M.
Based on PrairieView Partners's 13F filing for Q1 2021, filed 21 Apr 2021.